|
Friday, June 29, 2012
Rising Star, Peter Quillen
Wednesday, June 27, 2012
STRIKEFORCE: RONDA ROUSEY VS. SARAH KAUFMAN
Saturday, August 18 from Valley View Casino Center on Sports Arena Blvd. – San Diego, Calif.
TICKETS ON SALE FRIDAY, JUNE 29
Live on SHOWTIME® at 10 p.m. ET/PT (Delayed on West Coast)
Preliminary Card Live on SHOWTIME EXTREME® at 8 p.m. ET/PT (Delayed on West Coast)
LAS VEGAS – STRIKEFORCE® women’s bantamweight champion Ronda Rousey will make her highly-anticipated initial title defense against former champSarah Kaufman when STRIKEFORCE®: ROUSEY vs. KAUFMAN comes to Valley View Casino Center on Sports Arena Blvd. in San Diego, Calif. onSaturday, August 18. The five-round bout will air live on SHOWTIME® at 10 p.m. ET/PT (delayed on the West Coast) while preliminary fights will be shown live on SHOWTIME EXTREME® at 8 p.m. ET/PT (delayed on West Coast). Additional bouts will be announced in the coming days.
“We're excited to head back to the Valley View Casino Center in San Diego with the first title defense of bantamweight champion Ronda Rousey, arguably the best female fighter in the sport today," STRIKEFORCE CEO Scott Coker said. "She's submitted all of her opponents thus far, but number one contender Sarah Kaufman has the experience and tenacity to push her like no one else. This is a great title fight for STRIKEFORCE fans and we look forward to another tremendous night of fights in San Diego!"
Tickets for STRIKEFORCE®: ROUSEY vs. KAUFMAN, presented by Musclepharm®, go on sale to the general public on Friday, June 29 at 10 a.m. PT and are priced at $150, $100, $75 and $45. Tickets will be available at the Valley View Casino Center box office or online at www.valleyviewcasinocenter.com. Tickets are also available online at www.TicketMaster.com, by phone at 800-745-3000, and at all Ticketmaster outlets.
UFC® Fight Club™ members will have the opportunity to purchase tickets to this event Wednesday, June 27 at 10 a.m. PT, via the websitewww.UFCFightClub.com. A special Internet ticket pre-sale will be available to UFC newsletter and STRIKEFORCE Insider subscribers Thursday, June 28, starting at 10 a.m. PT. To access this pre-sale, users must register for the UFC newsletter through www.UFC.com and the STRIKEFORCE Insider throughwww.STRIKEFORCE.com.
Riding high off her recent championship performance over Miesha Tate this past March, Ronda Rousey (fighting out of Venice, Calif.) looks to continue her dominance in women’s MMA and make her first successful title defense this August in San Diego. A bronze medalist for the U.S. women’s 2008 Olympic Judo team, Rousey’s title win less than a year into her professional career solidified her illustrious transition into the sport of mixed martial arts. At 5-0, with all wins, including three additional victories at the amateur level, coming by way of armbar submission, “Rowdy” threatens victory every time the fights goes to the ground. In addition to Tate, past opponents Julia Budd and Sarah D’Alelio have found that out the hard way and no challenger to date has given Rousey any reason to think she can’t finish every one of her fights the exact same way.
A former champion herself, Sarah Kaufman (fighting out of Victoria, British Columbia, Canada) knows exactly what it takes to win and defend the title in the toughest division in women’s MMA. A brown belt in Brazilian jiu-jitsu, Kaufman is undoubtedly one of the toughest, most experienced and most well-rounded fighters in all of women’s mixed martial arts. At 15-1 with pro victories over Tate, Alexis Davis, Liz Carmouche and Shayna Bazler and currently riding a three-fight win streak, Kaufman made it known that she was unhappy when Rousey was awarded her title match with Tate, a match she felt she had earned. Now with her chance to prove she’s the true top competitor in the division, Kaufman will look to defeat Rousey and claim her second STRIKEFORCE bantamweight championship.
For more information or the latest STRIKEFORCE news, visit www.strikeforce.com. All bouts live and subject to change.
Owned and operated by Forza, LLC, a subsidiary of Zuffa, LLC, which also owns the Ultimate Fighting Championship® brand, STRIKEFORCE® is a world-class mixed martial arts promotion based in Las Vegas, Nev. that currently holds live events annually across the United States. First established as a mixed martial arts entity in 2006, STRIKEFORCE now broadcasts its events live on SHOWTIME® and has produced two live, primetime events on the CBS Television Network. With a growing roster featuring the world’s elite competitors, STRIKEFORCE has cemented its place as a leader in providing quality mixed martial arts action.
About Showtime Networks Inc.
Showtime Networks Inc. (SNI), a wholly-owned subsidiary of CBS Corporation, owns and operates the premium television networks SHOWTIME®, THE MOVIE CHANNEL™ and FLIX®, as well as the multiplex channels SHOWTIME 2™, SHOWTIME® SHOWCASE, SHOWTIME EXTREME®, SHOWTIME BEYOND®, SHOWTIME NEXT®, SHOWTIME WOMEN®, SHOWTIME FAMILY ZONE® and THE MOVIE CHANNEL™ XTRA. SNI also offers SHOWTIME HD™, THE MOVIE CHANNEL™ HD, SHOWTIME ON DEMAND® and THE MOVIE CHANNEL™ ON DEMAND. SNI also manages Smithsonian Networks, a joint venture between SNI and the Smithsonian Institution, which offers Smithsonian Channel™. All SNI feeds provide enhanced sound using Dolby Digital 5.1. SNI markets and distributes sports and entertainment events for exhibition to subscribers on a pay-per-view basis through SHOWTIME PPV®.
About Valley View Casino Center
Part of the AEG Facilities network of 100 venues worldwide, the Valley View Casino Center provides the widest range of premium entertainment to over 600,000 people each year. According to Billboard Magazine and News Today, the Valley View Casino Center was rated the #5 Facility in the world for venues with 10,001 to 15,000 seats. The Valley View Casino Center is the ideal multi‐purpose facility for guests of all ages to enjoy the best in live entertainment. Centrally located off of the I-8 and I-5 freeways, people from all over San Diego County can easily find the Valley View Casino Center. For further information on Valley View Casino Center visit www.valleyviewcasinocenter.com.
Tuesday, June 26, 2012
Cabrini Dinner June 13, 2012
Back on June 13, 2012 Cabrini Mission Foundation held their Annual Galla at The Pierre Hotel in NYC. As usual it was stacked with a who's who in the sports world. The raised over $30k for several food pantries across the city and well as a total of over $250K for Cabrini mission which will go to adding immigrants to this great nation of ours. Here are a few Picks from that night which include Carbini's own CEO Nick Vendikos as well as Howard Cross, Brett Yormark and Paul Malignaggi.
Hope you enjoy. If your interested in donating to Cabrini just click on the link: http://cabrinifoundation.org/
Thursday, June 21, 2012
Show Randall Bailey The Money
| ||||||||||||||||
Omega-3 lowers inflammation
Omega-3 lowers inflammation in overweight older adults: Brain, Behavior, and Immunity journal
New research shows that omega-3 fatty acid supplements can lower inflammation in healthy, but overweight, middle-aged and older adults, suggesting that regular use of these supplements could help protect against and treat certain illnesses.
Four months of omega-3 supplementation decreased one protein in the blood that signals the presence of inflammation by an average of more than 10 percent, and led to a modest decrease in one other inflammation marker. In comparison, participants taking placebos as a group saw average increases of 36 percent and 12 percent, respectively, of those same markers.
Chronic inflammation is linked to numerous conditions, including coronary heart disease, Type 2 diabetes, arthritis and Alzheimer’s disease, as well as the frailty and functional decline that can accompany aging.
Study participants took either 2.5 grams or 1.25 grams of active omega-3 polyunsaturated fatty acids in their supplements. Polyunsaturated fatty acids are considered “good fats” that, when consumed in proper quantities, are associated with a variety of health benefits. Study participants taking a placebo consumed pills containing less than 2 teaspoons per day of a mix of oils representing a typical American’s daily dietary oil intake.
“Omega-3 fatty acids may be both protective so that inflammation doesn’t go up, as well as therapeutic by helping inflammation go down,” said Jan Kiecolt-Glaser, professor of psychiatry and psychology at Ohio State University and lead author of the study.
“This is the first study to show that omega-3 supplementation leads to changes in inflammatory markers in the blood in overweight but otherwise healthy people. In terms of regulating inflammation when people are already healthy, this is an important study, in that it suggests one way to keep them healthy.”
The study is published online and scheduled for later print publication in the journalBrain, Behavior and Immunity.
The scientists recruited 138 adults – 45 men and 93 women – who were in good health, but who were either overweight or obese and lived sedentary lives. Their average age was 51 years. Based on body mass index, a measure of weight relative to height, 91 percent of the participants were overweight and 47 percent were obese.
Inflammation tends to accompany excess body fat, so the researchers recruited participants who were most likely high in pro-inflammatory blood compounds at the beginning of the study.
“We wanted to have enough room to see a downward trend. Most other trials testing the effects of omega-3 supplements on inflammation used people who were seriously diseased or skinny and healthy,” said Kiecolt-Glaser, also an investigator in Ohio State’s Institute for Behavioral Medicine Research (IBMR). “You can see results in people with serious diseases, but there’s a lot of other noise in that system. We wanted to make sure we were studying results in people who were fairly fit but who weren’t exercising, because exercise can clearly lower inflammation.”
The researchers also excluded from participation people taking a variety of medications to control mood, cholesterol and blood pressure as well as vegetarians, patients with diabetes, smokers, those routinely taking fish oil, people who got more than two hours of vigorous exercise each week and those whose body mass index was either below 22.5 or above 40.
Participants received either a placebo or one of two different doses of omega-3 fatty acids – either 2.5 grams or 1.25 grams per day. The supplements were calibrated to contain a ratio of the two fish oil fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), of seven to one. Previous research has suggested that EPA has more anti-inflammatory properties than does DHA.
After four months, participants who had taken the omega-3 supplements had significantly lower levels in their blood of two proteins that are markers of inflammation, also called pro-inflammatory cytokines. The low-dose group showed an average 10 percent decrease in the cytokine interleukin-6 (IL-6), and the high-dose group’s overall IL-6 dropped by 12 percent. In comparison, those taking a placebo saw an overall 36 percent increase in IL-6 by the end of the study.
Levels of the cytokine tumor necrosis factor-alpha (TNF-a) also dropped, but in a more modest way, by 0.2 percent and 2.3 percent in the low- and high-dose groups, respectively. The placebo group’s TNF-a increased by an average of 12 percent.
IL-6 and TNF-a are two of a family of six cytokines that, when stimulated, produce an inflammatory response to a stressor such as an injury or infection, said study co-author Ron Glaser, professor of molecular virology, immunology and medical genetics and director of the IBMR.
“You need this good inflammation for an initial response, but if it stays up, and inflammation becomes chronic, then you’ve got a problem,” Glaser said. “Our research and studies done by others have shown that these two cytokines are clearly related to overall health – and when they’re elevated in the blood, that is not good for overall health. So the more ways we can find to lower them, the better.”
Statistically, there was no significant difference in lowered inflammation between the two doses, but each dose clearly produced cytokine reductions that differed significantly from the placebo group.
“These data support the idea that a higher dose of omega-3 is not necessarily better than a lower dose in terms of prevention of inflammation,” said Martha Belury, professor of human nutrition at Ohio State and a co-author of the study.
However, levels of omega-3 fatty acids in participants’ blood increased according to which dose they consumed, which improved their ratio of omega-6 fatty acids to omega-3 fatty acids. The current typical American diet contains between 15 and 17 times more omega-6 than omega-3, a ratio that researchers suggest should be lowered to 4-to-1, or even 2-to-1, to improve overall health.
“Scientists tend to agree that the best way to gauge a person’s omega-3 status is to see whether that ratio goes down,” Belury said. “That’s what we saw in this study, and it was achieved through supplementation. We wanted participants to maintain normal diets and simply add this modest amount of oil to their existing diet. We expected and we found that their blood plasma omega-3 fatty acids went up in a dose-responsive manner.”
The Food and Drug Administration considers daily omega-3 supplementation of up to 3 grams to be “generally regarded as safe.” The doses in this study were within those safety parameters, but the researchers did not extend their findings to make a general recommendation about omega-3 supplementation.
“Although omega-3 fatty acids cannot take the place of good health behaviors, people with established inflammatory diseases or conditions may benefit from their use,” Kiecolt-Glaser said.
The researchers also sought to determine whether omega-3 fatty acids could reduce depression symptoms, but participants had relatively few symptoms to begin with so no significant reductions were seen. Depression is also associated with chronic inflammation, but research hasn’t yet fully defined the mechanisms behind that relationship.
###
This work was supported in part by grants from the National Institutes of Health. OmegaBrite, a company based in Waltham, Mass., supplied the supplements as an unrestricted gift but did not participate in the study design, results or publication.
Additional co-authors, all at Ohio State, include Rebecca Andridge of the Division of Biostatistics; William Malarkey of the IBMR and the departments of Psychiatry and Internal Medicine; and Beom Seuk Hwang of the IBMR and biostatistics.
Subscribe to:
Posts (Atom)